NATALIE RICKS: Open Payments
NPI 1801178033 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 51 payments from 14 companies in 2025. Trend: 2023 $1,581 · 2024 $1,211 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $212 |
| ABBVIE INC. | 12 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| Lilly USA, LLC | 5 | $78 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Incyte Corporation | 2 | $46 |
| Boston Scientific Corporation | 1 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $35 |
| UCB, Inc. | 1 | $28 |
| GENZYME CORPORATION | 1 | $23 |
Products named: COSENTYX, SKYRIZI, DUPIXENT, EBGLYSS, Sotyktu, OPZELURA, Lumenis Pulse 120H, Zoryve.
Industry payments across GA — which companies pay providers there.
